Our findings of the IgG-bound platelet-induced conversion of monocytes to regulatory cells open a new avenue for the development of IL-10-inducing therapeutic strategies for inflammation, autoimmune diseases and cancer. This evidence concerns the gene IL10 and autoimmune disease.